C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2006
10/26/2006	WO2006111784A1 Method for enlarging the range of applicability of multiple displacement amplification of linear dna
10/26/2006	WO2006111749A2 Pulmonary disease marker
10/26/2006	WO2006111743A2 Identifying lantibiotic gene clusters and novel lantibiotic genes
10/26/2006	WO2006111729A1 Method and device for nucleic acid sequencing using a planar wave guide
10/26/2006	WO2006111544A1 Method for inhibition of the translation and/or replication of a sequence of rna by multimerisation of one of the non-coding folded rna regions thereof
10/26/2006	WO2006111238A1 Method for screening mtp-inhibiting compounds
10/26/2006	WO2006111035A1 Method for the identification of possibly harmful receptor tyrosine kinase (rtk) mutations and of inhibitors or medication directed against rtk mutantstitle
10/26/2006	WO2006111029A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
10/26/2006	WO2006111028A1 Pcr for mrsa sccmec typing
10/26/2006	WO2006094798A9 Use of panel of pairs of primers complementary to reporter genes of cell differentiation
10/26/2006	WO2006086995A9 Electric conductors, fermentation catalysis and chemical analysis devices
10/26/2006	WO2006086197A3 Rapid-response gas sensing element
10/26/2006	WO2006085746A3 Diagnosis of metastases in hnscc tumours
10/26/2006	WO2006079567A3 Brassica plant comprising a mutant fatty acid desaturase
10/26/2006	WO2006077126A3 Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients
10/26/2006	WO2006075996A3 Reporter plasmid phage packaging system for detection of bacteria
10/26/2006	WO2006069306A3 A knockout mouse for the tumor suppressor gene anx7
10/26/2006	WO2006066965A3 Mrna ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer
10/26/2006	WO2006063703A3 Single nucleotide polymorphism (snp) associated to type ii diabetes
10/26/2006	WO2006060598A3 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/26/2006	WO2006050333A3 Methods and compositions for modulating apoptosis
10/26/2006	WO2006047484A3 Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation
10/26/2006	WO2006044263A3 Treatment of herpes
10/26/2006	WO2006040549A3 Labelling and sequencing of nucleic acids
10/26/2006	WO2006022882A3 Canine pancreatic lipse
10/26/2006	WO2006002240A8 Computer systems and methods for constructing biological classifiers and uses thereof
10/26/2006	WO2005124352B1 Method for determining aggrecanase activities
10/26/2006	WO2005119261A3 Glut5 transporters expressed in cancer cells
10/26/2006	WO2005086938A3 Artificial mutation controls for diagnostic testing
10/26/2006	WO2005086770A9 Methods for genetic analysis
10/26/2006	WO2005083129A8 Detection of human papillomavirus
10/26/2006	WO2005062788A3 Prostate specific proteins expressed in cancer and methods of use thereof
10/26/2006	WO2005060542A3 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
10/26/2006	WO2005035719A3 Modified luciferase
10/26/2006	WO2005011947A9 Image processing method and system for microfluidic devices
10/26/2006	WO2004031346A3 Methods and compositions concerning designed highly-specific nucleic acid binding proteins
10/26/2006	WO2003093789A3 Method for measuring ion channel activity
10/26/2006	WO2002101008A3 Intracellular signaling molecules
10/26/2006	WO2002090522A3 Use of phosphorothiolate polynucleotides in ligating nucleic acids
10/26/2006	WO2002078420A3 Molecules for disease detection and treatment
10/26/2006	US20060242739 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants
10/26/2006	US20060242737 Modulation of flowering time by the pft1 locus
10/26/2006	US20060242731 DNA shuffling to produce herbicide selective crops
10/26/2006	US20060242729 Polynucleotides encoding proteins involved in plant metabolism
10/26/2006	US20060242725 for importing nucleic acids, such as DNA, into the nuclei of osteoblast lineage cells (the bone forming cells of the skeleton)
10/26/2006	US20060242724 Receptor
10/26/2006	US20060242722 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells
10/26/2006	US20060242721 Gene families associated with liver cancer
10/26/2006	US20060241870 Method for selection of optimal microarray probes
10/26/2006	US20060241365 Implantable Biosensor and Methods of Use Thereof
10/26/2006	US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis
10/26/2006	US20060241284 Transmembrane protein amigo and uses thereof
10/26/2006	US20060241185 Antibiotics targeting MreB
10/26/2006	US20060241150 P38 kinase inhibitor compositions and methods of using the same
10/26/2006	US20060241139 Treatment of DNA damage related disorders
10/26/2006	US20060241033 Markers for pre-cancer and cancer calls and the method to interfere with cell proliferation therein
10/26/2006	US20060241031 Assay
10/26/2006	US20060241030 Irs modulators
10/26/2006	US20060241015 Cancer genes
10/26/2006	US20060240551 Immunotherapy, immunogens, hybridomas
10/26/2006	US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles
10/26/2006	US20060240521 DNA sequences for regulating transcription
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240516 Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain
10/26/2006	US20060240515 Soluble fragments of the SARS-CoV spike glycoprotein
10/26/2006	US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents
10/26/2006	US20060240507 Cationic anti-microbial peptides and methods of use thereof
10/26/2006	US20060240506 Method for isolating and culturing unculturable microorganisms
10/26/2006	US20060240505 Identification of Targets of Antimicrobial Compounds
10/26/2006	US20060240504 Evaluating bacterial lethality of containerized food production
10/26/2006	US20060240503 Protease detection assay
10/26/2006	US20060240502 GTP cyclohydrolase II as a target for fungicides
10/26/2006	US20060240501 Removing fructosyl group from a fructosylated peptide or protein by reacting with an aqueous Pyrus pyrifolia, Vitis vinifera, or Daucus carota extract containing an enzyme that removes the fructose without removing an amino acid residue; detecting reaction products
10/26/2006	US20060240500 Diagnosis of kidney damage and protection against same
10/26/2006	US20060240499 Methods for determining phosphoryltransferase activity using adenosine 5'-triphosphate (ATP)-gamma-S
10/26/2006	US20060240494 Biocidal molecules, macromolecular targets and methods of production and use
10/26/2006	US20060240493 Cca1 as an antifungal target
10/26/2006	US20060240483 Inducing signalosome formation in cells, lysing and incubating the cell lysate on a solid phase coated with antibody capable of capturing the receptor within the signalosome, separating solid phase from the cell lysate, and detecting and measuring the amount of the protein bound to the solid phase
10/26/2006	US20060240471 Genetic test for the identification of carriers of complex vertebral malformations in cattle
10/26/2006	US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product
10/26/2006	US20060240469 Method for generating transcriptionally active DNA fragments
10/26/2006	US20060240468 Method of reverse transcription
10/26/2006	US20060240467 Analyte sampling element, analyte treatment device and analyte treatment method
10/26/2006	US20060240466 Prevention of Type 1 diabetes and other non-polio enterovirus diseases
10/26/2006	US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel
10/26/2006	US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
10/26/2006	US20060240463 Markers associated with the therapeutic efficacy of glatiramer acetate
10/26/2006	US20060240462 Methods for amplification and detection of nucleic acids
10/26/2006	US20060240461 Methods for detecting nemaline myopathy
10/26/2006	US20060240460 Method for detecting methylated CpG islands
10/26/2006	US20060240459 ClCKb mutation as a diagnostic and therapeutical target
10/26/2006	US20060240458 Superimposed, multilayer, hermetically sealed
10/26/2006	US20060240457 Methods for characterizing agonists and partial agonists of target molecules
10/26/2006	US20060240456 Nanosized biological container and manufacture thereof
10/26/2006	US20060240455 Oxazine derivatives
10/26/2006	US20060240454 MMethod of analyzing breast cancer susceptibility and resistance
10/26/2006	US20060240453 Clinically intelligent diagnostic devices and methods

1 ... 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 ... 3003